PROCESSES FOR PREPARING ANHYDROUS AND HYDRATE FORMS OF ANTIHISTAMINIC PIPERIDINE DERIVATIVES, POLYMORPHS AND PSEUDOMORPHS THEREOF
The present invention is related to novel processes for preparing anhydrous and hydrated forms of piperidine derivatives, polymorphs and pseudomorphs thereof of the formulas which are useful as antihistamines, antiallergic agents and bronchodilators.
1 . Form I′ hydrated 4-[4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]-1-hydroxybutyl]-α,α-dimethylbenzeneacetic acid.
2 . Form II′ hydrated 4-[4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]-1-hydroxybutyl]-α,α-dimethylbenzeneacetic acid.
3 . Form III′ hydrated 4-[4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]-1-hydroxybutyl]-α,α-dimethylbenzeneacetic acid.
4 . Form IV′ hydrated 4-[4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]-1-hydroxybutyl]-α,α-dimethylbenzeneacetic acid.
5 . Form V′ hydrated 4-[4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]-1-hydroxybutyl]-α,α-dimethylbenzeneacetic acid.
6 . Form VII′ hydrated 4-[4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]-1-hydroxybutyl]-α,α-dimethylbenzeneacetic acid.
7 . Form IX′ hydrated 4-[4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]-1-hydroxybutyl]-α,α-dimethylbenzeneacetic acid.
8 . Form VII′ anhydrous 4-[4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]-1-hydroxybutyl]-α,α-dimethylbenzeneacetic acid.
9 - 27 . (canceled)
28 . A pharmaceutical composition comprising an effective antiallergic amount of a compound of claim 1 and an inert carrier.
29 . A pharmaceutical composition comprising an effective antiallergic amount of a compound of claim 2 and an inert carrier.
30 . A pharmaceutical composition comprising an effective antiallergic amount of a compound of claim 3 and an inert carrier.
31 . A pharmaceutical composition comprising an effective antiallergic amount of a compound of claim 4 and an inert carrier.
32 . A pharmaceutical composition comprising an effective antiallergic amount of a compound of claim 5 and an inert carrier.
33 . A pharmaceutical composition comprising an effective antiallergic amount of a compound of claim 6 and an inert carrier.
34 . A pharmaceutical composition comprising an effective antiallergic amount of a compound of claim 7 and an inert carrier.
35 . A pharmaceutical composition comprising an effective antiallergic amount of a compound of claim 8 and an inert carrier.
36 - 39 . (canceled)
40 . A method of treating an allergic reaction in a patient in need thereof which comprises administering to said patent an anti-allergically effective amount of a compound of claim 1 .
41 . A method of treating an allergic reaction in a patient in need thereof which comprises administering to said patent an anti-allergically effective amount of a compound of claim 2 .
42 . A method of treating an allergic reaction in a patient in need thereof which comprises administering to said patent an anti-allergically effective amount of a compound of claim 3 .
43 . A method of treating an allergic reaction in a patient in need thereof which comprises administering to said patent an anti-allergically effective amount of a compound of claim 4 .
44 . A method of treating an allergic reaction in a patient in need thereof which comprises administering to said patent an anti-allergically effective amount of a compound of claim 5 .
45 . A method of treating an allergic reaction in a patient in need thereof which comprises administering to said patent an anti-allergically effective amount of a compound of claim 6 .
46 . A method of treating an allergic reaction in a patient in need thereof which comprises administering to said patent an anti-allergically effective amount of a compound of claim 7 .
47 . A method of treating an allergic reaction in a patient in need thereof which comprises administering to said patent an anti-allergically effective amount of a compound of claim 8 .
48 - 64 . (canceled)